Testing effectiveness (Phase 2)Study completedNCT00265122
What this trial is testing
The Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
Who this might be right for
Crohn Disease
Centocor, Inc. 131
Showing 20 of 196 results